What's Happening?
Swiss startup Planetary has raised $28 million to enhance its fermentation infrastructure and licensing platform. The funding includes a $20 million Series A equity round led by Radikal Capital and Oetker Ventures, with additional credit support. Planetary's
business model focuses on producing mycoprotein as a B2B ingredient and licensing its 'BioBlocks' fermentation platform. This platform allows partners to convert low-value side streams into high-value ingredients. The company aims to supply mycoprotein at cost parity with conventional proteins and is exploring collaborations to produce mycoprotein in India at industrial scale. Planetary's approach emphasizes controlling the full value chain to achieve cost-effective production.
Why It's Important?
Planetary's funding and business model reflect a growing trend in the food industry towards sustainable and cost-effective protein alternatives. By focusing on fermentation technology, Planetary addresses the increasing demand for plant-based and alternative proteins, which are crucial for reducing the environmental impact of traditional meat production. The company's strategy to control the production process and infrastructure highlights the importance of efficiency and cost management in the competitive food tech sector. This development could influence other companies to adopt similar models, potentially accelerating the shift towards more sustainable food systems.
What's Next?
Planetary plans to engage with additional investors for a second closing of the funding round. The company will continue to expand its production capabilities and explore new markets for its mycoprotein products. As the demand for alternative proteins grows, Planetary's success could lead to further innovations in fermentation technology and broader adoption of sustainable food production practices. The company's collaboration with partners in India and other regions may also pave the way for global expansion and increased accessibility to alternative protein sources.
